牛牛AI助理已提取核心訊息
TC BioPharm has announced a General Meeting (GM) of shareholders to be held on March 14, 2024, at 2:00 p.m. UK time, at the company's registered office in Holytown, Motherwell. The meeting will address two ordinary resolutions: the authorization to adjourn the GM if necessary to permit further solicitation of proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which the company indicates is necessary to fund operations and implement its business strategy. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and those holding American Depositary Shares (ADSs) must submit their voting instructions by March 8, 2024. The GM notice includes detailed voting procedures and the Board's rationale for the proposed resolutions, highlighting the potential impact on the company's capital structure and governance.
TC BioPharm has announced a General Meeting (GM) of shareholders to be held on March 14, 2024, at 2:00 p.m. UK time, at the company's registered office in Holytown, Motherwell. The meeting will address two ordinary resolutions: the authorization to adjourn the GM if necessary to permit further solicitation of proxies, and the authorization to issue securities in one or more non-public offerings in accordance with Nasdaq Marketplace Rule 5635(d). The latter is a strategic move to raise additional capital up to $4 million, which the company indicates is necessary to fund operations and implement its business strategy. The Board of Directors unanimously recommends shareholders vote in favor of the resolutions, emphasizing their alignment with the company's best interests. Shareholders registered by March 12, 2024, are entitled to vote, and those holding American Depositary Shares (ADSs) must submit their voting instructions by March 8, 2024. The GM notice includes detailed voting procedures and the Board's rationale for the proposed resolutions, highlighting the potential impact on the company's capital structure and governance.
TC BioPharm宣佈股東大會（GM）將於英國時間2024年3月14日下午2點在該公司位於馬瑟韋爾霍利敦的註冊辦事處舉行。會議將討論兩項普通決議：授權通用汽車在必要時休會以允許進一步徵集代理人，以及授權根據納斯達克市場規則5635（d）在一次或多次非公開發行中發行證券。後者是一項戰略舉措，旨在籌集高達400萬美元的額外資金，該公司表示，這對於爲運營提供資金和實施其業務戰略是必要的。董事會一致建議股東對這些決議投贊成票，強調這些決議符合公司的最大利益。在2024年3月12日之前註冊的股東有權投票，持有美國存托股份（ADS）的股東必須在2024年3月8日之前提交投票指示。通用汽車的通知包括詳細的投票程序和董事會對擬議決議的理由，強調了對公司資本結構和治理的潛在影響。
TC BioPharm宣佈股東大會（GM）將於英國時間2024年3月14日下午2點在該公司位於馬瑟韋爾霍利敦的註冊辦事處舉行。會議將討論兩項普通決議：授權通用汽車在必要時休會以允許進一步徵集代理人，以及授權根據納斯達克市場規則5635（d）在一次或多次非公開發行中發行證券。後者是一項戰略舉措，旨在籌集高達400萬美元的額外資金，該公司表示，這對於爲運營提供資金和實施其業務戰略是必要的。董事會一致建議股東對這些決議投贊成票，強調這些決議符合公司的最大利益。在2024年3月12日之前註冊的股東有權投票，持有美國存托股份（ADS）的股東必須在2024年3月8日之前提交投票指示。通用汽車的通知包括詳細的投票程序和董事會對擬議決議的理由，強調了對公司資本結構和治理的潛在影響。
有用
沒用